Press Releases
2011 - 2005

Dec-7, 2011

Innovative Fragment Library Concept Allows Identification of New Lead Compounds for Immediate Pre-Clinical Use; Bicoll and Crelux to Market Co-Developed New Fragment Service Platform
see full text

July-20, 2011

Bicoll and Naturalpha announce Nutraceutical Research Alliance; European-Funded Research Cooperation Olnorme II Extended
see full text in English language
see full text in German language

May-11, 2011

Bicoll as Partner of a € 2.7 M European-Funded Euro TransBio Program; Olnorme II Program Focuses on the Development of a New Class of Drug Candidates for the Prevention and Treatment of Cardio Metabolic Diseases with an Inflammatory Component
see full text

Jun-22, 2010

Bicoll and the European Molecular Biology Laboratory (EMBL) announce results of their joint research project on the identification of aurora kinase inhibitors
see full text

Feb-22, 2010

Bicoll Biotechnology (Shanghai) Co. Ltd. receives grant from Shanghai Science Technology Committee
see full text

Oct-06, 2009

Bicoll Biotechnology (Shanghai) Co. Ltd. completes modernization of its laboratory facilities for medicinal chemistry
see full text

Sep-01, 2009

Bicoll and Genfit announce the identification of active compounds for inflammatory diseases - First candidates de-orphanize nuclear receptor in their joint project OLNORME
see full text

Jun-03, 2009

Bicoll announces a new Advisory Board member - Dr. Michael Bogenstaetter officially appointed to join Bicoll's Advisory Board
see full text

Jul-03, 2007

Bicoll announces the signing of a new partnership with Genfit and the partial financing of a 3.2 million euro joint EuroTrans-Bio project by ERA-Net/ European Commission
see full text

Dec-06, 2006

Ricerca Biosciences, LLC and The Bicoll Group enter significant collaboration agreement
see full text

Oct-25, 2005

Bicoll (Shanghai) Co. Ltd. expands its laboratory facilities within Zhangjiang Hi-Tech Park/Shanghai
see full text

Press Releases2011 - 2005